Aclaris Therapeutics, Inc (ACRS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Dermatologik va immun patologiyalarini davolashga yo'naltirilgan biotexnologiya sektori hozirda jadal o'smoqda, bu esa Aclaris Therapeutics (ACRS) aktivlariga bo'lgan qiziqishni oshirmoqda. Aclaris Therapeutics (ACRS) revmatologiya va teri uchun dori vositalari portfelini ishlab chiqish orqali risklarni minimallashtirmoqda. Ko'rsatkich 0.01 darajasida turibdi. GURU.Markets platformasidagi ushbu narxlar grafigi, kichik molekulali yallig'lanishga qarshi ishlanmalari sanoat mutaxassislari tomonidan ishonch bildirilgan brendning yuqori salohiyatini tasdiqlaydi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ACRS_-_Aclaris-Therapeutics_-_Long-Term-Debt-to-Capital "ACRS: Aclaris Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 | 👁️GURU.Markets👁️")
Aclaris Therapeutics (ACRS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aclaris Therapeutics|ACRS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati aclaristx.com|ACRS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Aclaris Therapeutics, Inc.|ACRS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Aclaris Therapeutics|Tezkor likvidlik ko‘rsatkichi aclaristx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Aclaris Therapeutics Inc. - ACRS
Ushbu koeffitsiyent kapital tarkibida uzoq muddatli majburiyatlarning ulushini belgilaydi, bu esa moliyaviy barqarorlikni va biznesning qarz mablag'lariga bog'liqlik darajasini baholash imkonini beradi. Uzoq muddatli qarzlarning kapitalga nisbatini tahlil qilish Aclaris Therapeutics (ACRS) uchun juda muhimdir, chunki ulkan R&D xarajatlari va patent nizolari klinik sinovlar risklarini yumshatish uchun sezilarli likvidlik buferini talab qiladi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati rigel.com|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzning kapitalga nisbati rapt.com (RAPT)|Uzoq muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics JBIO|Uzoq muddatli qarzning kapitalga koeffitsiyenti KYTX|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Cabaletta Bio Inc. CABA|Ventyx Bio (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|THTX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AVTX|ELDN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati CLYM|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATYR|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ImageneBio Inc|shattucklabs.com (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Equillium - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. (ACET) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB - Uzoq muddatli qarzning kapitalga nisbati|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR: Uzoq muddatli kreditlarning kapitalga nisbati|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Akari Therapeutics PLC (AKTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzdorlikning kapitalga nisbati edesabiotech.com (EDSA)|iBio - Uzoq muddatli qarzning kapitalga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|APVO: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzdorlikning kapitalga nisbati aditxt.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati